UY30129A1 - PHARMACEUTICAL COMPOSITIONS - Google Patents

PHARMACEUTICAL COMPOSITIONS

Info

Publication number
UY30129A1
UY30129A1 UY30129A UY30129A UY30129A1 UY 30129 A1 UY30129 A1 UY 30129A1 UY 30129 A UY30129 A UY 30129A UY 30129 A UY30129 A UY 30129A UY 30129 A1 UY30129 A1 UY 30129A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutical compositions
formulations
amorphous
forms
pharmaceutical
Prior art date
Application number
UY30129A
Other languages
Spanish (es)
Inventor
Gaspar Felipe
Hurter Patericia
Krogmeier Stephanie Lynn
Sanghvi Tapan
Jeffrey P Katstra
Kevin John Bittorf
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of UY30129A1 publication Critical patent/UY30129A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Formas y formulaciones de VX-950 amorfo y sus usos.Forms and formulations of amorphous VX-950 and its uses.

UY30129A 2006-02-02 2007-02-02 PHARMACEUTICAL COMPOSITIONS UY30129A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76465406P 2006-02-02 2006-02-02
US78442706P 2006-03-20 2006-03-20

Publications (1)

Publication Number Publication Date
UY30129A1 true UY30129A1 (en) 2007-08-31

Family

ID=38813265

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30129A UY30129A1 (en) 2006-02-02 2007-02-02 PHARMACEUTICAL COMPOSITIONS

Country Status (1)

Country Link
UY (1) UY30129A1 (en)

Similar Documents

Publication Publication Date Title
AR059978A1 (en) PHARMACEUTICAL COMPOSITIONS
SG153800A1 (en) Pharmaceutical compositions
ECSP12012011A (en) CERTAIN TRIAZOLOPIRIDINS AND TRIAZOLOPIRAZINS, COMPOSITIONS OF THESE AND THEIR EMPLOYMENT METHODS
LTPA2015051I1 (en) Compounds and compositions as hedgehog path modulators
DK1763673T3 (en) APPLICATIONS OF GEL FORMULATIONS
DOP2013000212A (en) CRYSTAL FORMS OF DIMETOXI-DOCETAXEL AND ITS PREPARATION PROCEDURES
BRPI0719840A2 (en) DOSAGE FORMS OF NON-MUCOADESIVE FILMS
ECSP13012877A (en) SOLID FORMS SDE 3- (5-AMINO-2-methyl -4- oxo-4H-QUINAZOL1N-3-IL) - PIPERIDIN-2, 6-DIONA, AND ITS PHARMACEUTICAL COMPOSITIONS AND USES
DK2137537T3 (en) Compositions and uses for the treatment of multiple sclerosis
AR060978A1 (en) ANTIBODIES AND IMMUNOCATE PLAYERS AND THEIR USES
DK1937824T3 (en) Compositions of tRNA and uses thereof
ECSP088759A (en) PHARMACEUTICAL COMPOSITIONS
BRPI0720124A2 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
BRPI0719369A2 (en) PROSTHESIS HOLDER AND APPLICATIONS
DK2297312T3 (en) Alpha-amylase variants of Bacillus subtilis and methods for their use
AR063532A1 (en) ANTIBODIES AND IMMUNOCATE PLAYERS AND THEIR USES
BRPI0912717A2 (en) PHARMACEUTICAL COMPOSITION, AND, USE OF 5-AZACYTIDINE
DK2181330T3 (en) Compositions and agents for the diagnosis of microbial infections
NL2000439A1 (en) Therapeutic applications of inhibitors of RTP801.
CR20120362A (en) CERTAIN TRIAZOLOPIRIDINS AND TRIAZOLOPIRAZINS, COMPOSITIONS OF THESE AND THEIR EMPLOYMENT METHODS
FR2902647B1 (en) MAKE-UP COMPOSITIONS OF KERATINIC MATERIALS
DK2097068T3 (en) FORMULATIONS OF PEG-INTERFERON-ALPHA CONJUGATES
BRPI0817053A2 (en) Orlistat Pharmaceutical Formulations
BRPI0820260A2 (en) Anthelmintic composition and use of composition
AR060849A1 (en) HYDROPHOBICALLY MODIFIED CATIONIC POLYMERS AND THEIR COMPOSITIONS FOR PERSONAL CARE

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120605